Proton Donor Acidity Controls Selectivity in Nonaromatic Nitrogen Heterocycle Synthesis
Simon Duttwyler, Shuming Chen, Michael K. Takase et al. · Science · 2013
Piperidines are prevalent in natural products and pharmaceutical agents and are important synthetic targets for drug discovery and development. We report on a methodology that provides highly substituted piperidine derivatives with regiochemistry selectively tunable by varying the strength of acid used in the reaction. Readily available starting materials are first converted to dihydropyridines via a cascade reaction initiated by rhodium-catalyzed carbon-hydrogen bond activation. Subsequent divergent regio- and diastereoselective protonation of the dihydropyridines under either kinetic or thermodynamic control provides two distinct iminium ion intermediates that then undergo highly diastereoselective nucleophilic additions. X-ray structural characterization of both the kinetically and thermodynamically favored iminium ions along with density functional theory calculations provide a theoretical underpinning for the high selectivities achieved for the reaction sequences.
Cited by 76 works. doi:10.1126/science.1230704
Authors
- Simon Duttwyler
- Shuming Chen
- Michael K. Takase
- Kenneth B. Wiberg
- Robert George Bergman
- Jonathan A. Ellman
References
- A short history of SHELX
- Phase annealing in SHELX-90: direct methods for larger structures
- Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
- Domino Reactions in Organic Synthesis
- Catalytic C–H functionalization by metal carbenoid and nitrenoid insertion
- Allylic 1,3-strain as a controlling factor in stereoselective transformations
- CH Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals
- Organocatalytic cascade reactions as a new tool in total synthesis
- Rhodium(III)-Catalyzed Heterocycle Synthesis Using an Internal Oxidant: Improved Reactivity and Mechanistic Studies
- The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?